Nestlé, the world’s largest food and beverage company, is in “advanced negotiations” to sell its remaining ice cream business to joint venture partner Froneri. The division, which includes household names like Häagen-Dazs and Drumstick, is valued at just under $1.3 billion.
The planned sale marks a critical moment in Nestlé’s ongoing turnaround. But as the company attempts to shed “distractions” and simplify its sprawling portfolio, operational crises—including a highly sensitive infant formula recall—are testing new leadership.
The move reflects CEO Philipp Navratil’s broader effort to trim the fat and focus on higher-performing categories. Navratil, who took over in September following the abrupt dismissal of former CEO Laurent Freixe, stated that the company will now prioritize four core businesses: coffee, pet care, nutrition, and food and snacks.
On a call with reporters, Navratil described the company’s six ice cream brands as a distraction lacking global scale. The ice cream business presents unique operational challenges, including seasonal demand swings, complex frozen supply chains, and high distribution costs.
Nestlé is not alone in exiting this category. Unilever recently spun off its own ice cream unit, creating The Magnum Ice Cream Company, as part of a similar portfolio simplification strategy. This mirrors a broader trend of corporate restructuring across the sector, much like the maneuvers we highlighted in Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal, as legacy consumer brands consolidate to protect margins.
To boost long-term sales growth, Nestlé is aggressively leaning into efficiency. The company is in the process of cutting approximately 16,000 jobs worldwide as part of a sweeping cost-reduction program. By heavily integrating automation and artificial intelligence into its operations, Nestlé is accelerating the workforce transformations we explored in The AI Shake-Up: Which Jobs Are Most at Risk.
However, Navratil’s turnaround efforts have been complicated by a major product safety crisis. Last month, Nestlé recalled batches of infant formula—including Guigoz in France and SMA in the U.K.—in dozens of countries after detecting traces of cereulide, a toxin that can cause vomiting and diarrhea.
France’s health ministry is currently investigating the deaths of three infants who consumed the affected formula, though officials note no causal link has been scientifically established. Navratil emphasized that Nestlé’s internal quality controls led to the discovery of the toxin, but the fallout is widening. Following the recall, the European Union introduced stricter limits on acceptable cereulide levels, and French rival Danone has also recalled certain formula products in the U.K.
Nestlé’s planned ice cream sale signals a sharper focus on core, scalable businesses. Portfolio simplification has become a survival strategy among global consumer goods companies seeking steadier growth in a volatile economy.
However, executing a turnaround at scale is rarely smooth. The combination of 16,000 job cuts and the fallout from a sensitive formula recall underscores the immense operational friction the company faces. For investors looking ahead to Wall Street Forecast 2026, the key question is whether this aggressive streamlining can deliver sustainable growth while restoring confidence in one of the world’s most recognizable consumer brands.
View All News